Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia (original) (raw)

• Kovelman JA, Scheibel AB . A neurohistological correlate of schizophrenia Biol Psychiatry 1984; 19: 1601–1621
  CAS Google Scholar
• Weinberger DR, Lipska BK . Cortical maldevelopment, anti-psychotic drugs and schizophrenia: a search for common ground Schizophrenia Res 1995; 16: 87–110
  Article CAS Google Scholar
• Gualtieri CT, Adams A, Shen D, Loiselle D . Minor physical anomalies in alcoholic and schizophrenic adults and hyperactive and autistic children Am J Psychiatry 1982; 139: 640–643
  Article CAS Google Scholar
• Delisi LE, Hoff AL, Schwartz JE, Shields GW, Halthore SN, Gupta SM et al. Brain morphology in first episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study Biol Psychiatry 1991; 29: 159–175
  Article CAS Google Scholar
• Hyman C, Hofer M, Barde Y, Juhasz M, Yancopoulos G, SaL Squinto R . BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra Nature 1991; 350: 230–232
  Article CAS Google Scholar
• Thoenen H . Neurotrophins and neuronal plasticity Science 1995; 270: 593–598
  Article CAS Google Scholar
• Altar A, Boylan C, Jackson C, Hershenson S, Miller J, Wiegand S et al. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo Proc Natl Acad Sci USA 1992; 89: 11347–11351
  Article CAS Google Scholar
• Blochl A, Sirrenberg C . Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via the Trk and p75Lntr receptors J Biol Chem 1996; 271: 21100–21107
  Article CAS Google Scholar
• Seroogy KB, Lundgren KH, Tran TMD, Guthrie KM, Isackson PJ, Gall C . Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophin factor and neurotrophin-3 mRNAs J Comp Neurol 1994; 342: 321–334
  Article CAS Google Scholar
• Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain Nature 1997; 389: 856–860
  Article CAS Google Scholar
• Carlsson A, Lindqvist M . Effect of chlorpromazine or haloperidol on the formation of 3-methoxytyramine and normetanephrine in mouse brain Acta Pharmacol Toxicol 1963; 20: 140–144
  Article CAS Google Scholar
• Di Chiara G, Imperato A . Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats Proc Natl Acad Sci USA 1988; 85: 5274–5278
  Article CAS Google Scholar
• Guillin O, Damier L, Griffon N, Diaz J, Carroll P, Schwartz J et al. Role of brain-derived neurotrophic factor in the control of D3 receptor expression Eur Neuropsychopharmacol 1999; 9, suppl 5: S184
  Article Google Scholar
• Pröschel M, Saunders A, Roses A, Müller C . Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF) Hum Mol Genet 1992; 1: 353
  Article Google Scholar
• Krebs MO, Sautel F, Bourdel MC, Sokoloff P, Schwartz JC, Olie JP et al. Dopamine D3 receptor gene variants and substance abuse in schizophrenia Mol Psychiatry 1998; 3: 337–341
  Article CAS Google Scholar
• Hawi Z, Straub RE, O'Neill A, Kendler KS, Walsh D, Gill M . No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families Psychiatry Res 1998; 81: 111–116
  Article CAS Google Scholar
• Sasaki T, Dai XY, Kuwata S, Fukuda R, Kunugi H, Hattori M et al. Brain-derived neurotrophic factor gene and schizophrenia in Japanese subjects Am J Med Genet) 1997; 74: 443–444
  Article CAS Google Scholar
• Gorwood P, Leboyer M, Jay M, Payan C, Feingold J . Gender and age at onset in schizophrenia: impact of family history Am J Psychiatry 1995; 152: 298–212
  Google Scholar
• Numan S, Lane-Ladd S, Zhang L, Lundgren K, Russel D, Seroogy K et al. Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal J Neurosci 1998; 18: 10700–10708
  Article CAS Google Scholar
• Segman R, Neeman T, Heresco-Levy U, Finkel B, Karagichey L, Schlafman M et al. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia Mol Psychiatry 1999; 4: 247–253
  Article CAS Google Scholar
• Steen VM, Lovelie R, MacEwan T, McCreadue RG . Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients Mol Psychiatry 1997; 2: 139–145
  Article CAS Google Scholar
• Gurevich E, Bordelon Y, Shapiro R, Arnold S, Gur R, Joyce J . Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia Arch Gen Psychiatry 1997; 54: 225–232
  Article CAS Google Scholar
• Sokoloff P, Giros B, Martres M, Bouthenet M, Schwartz J . Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics Nature 1990; 347: 146–151
  Article CAS Google Scholar
• Karayiorgou M, Gogos J . Dissecting the genetic complexity of schizophrenia Mol Psychiatry 1997; 2: 211–223
  Article CAS Google Scholar
• Endicott J, Spitzer RL . A diagnostic interview: a schedule for affective disorders and schizophrenia Arch Gen Psychiatry 1978; 35: 837–844
  Article CAS Google Scholar
• APA . Diagnostic and Statistical Manual of Mental Disorders. Revised, 3rd edn APA: Washington DC 1987
  Google Scholar
• Kay SR, Fiszbein A, Opler LA . The positive and negative symptom scale (PANSS) Schizophr Bull 1987; 13: 261–276
  Article CAS Google Scholar
• Häfner H, Maurer K, Löffler W, Bustamante S, van der Heiden W, Riecher-Rössler A et al. Onset and early course of schizophrenia. In: Häfner H, Gattaz (eds) Search for the Causes of schizophrenia Springer Verlag: Berlin-Heidelberg-New York 1995; 43–66
  Chapter Google Scholar
• Beratis S, Gabriel J, Holdas S . Age at onset in subtypes of schizophrenic disorders Schiz Bull 1994; 20: 287–296
  Article CAS Google Scholar
• May PR, Dencker SJ, Hubbard JW, Midha KK, Liberman RP . A systematic approach to treatment resistance in schizophrenic disorders. In: Dencker S, Kulhanel F (eds). Treatment Resistance in Schizophrenia Vieweg Verlag: Wiesbaden 1988
  Google Scholar